Cyp3a Inducers + Remibrutinib Interaction
Majorinteraction on record
Description
Concomitant use decreases remibrutinib exposure and may decrease efficacy. Avoid concomitant use.
Mechanism
Remibrutinib is a CYP3A4 substrate; induction decreases exposure
Source: NLP:remibrutinib